Filings

6 documents · 47 matches

1. VTGN Vistagen Therapeutics, Inc. 10-K 2026-06-15

   Item 8. Financial Statements and Supplementary Data

   Going Concern, we evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about our ability
   10 matches in this document Show context Copy citation

2. VTGN Vistagen Therapeutics, Inc. 10-K 2025-06-17

   Item 8. Financial Statements and Supplementary Data

   Going Concern, we evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about our ability
   8 matches in this document Show context Copy citation

3. VTGN Vistagen Therapeutics, Inc. 10-Q 2026-02-12

   Item 1. Condensed Consolidated Financial Statements

   Going Concern, we evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about our ability
   9 matches in this document Show context Copy citation

4. VTGN Vistagen Therapeutics, Inc. 10-Q 2025-11-13

   Item 1. Condensed Consolidated Financial Statements

   Going Concern, we evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about our ability
   7 matches in this document Show context Copy citation

5. VTGN Vistagen Therapeutics, Inc. 10-Q 2026-08-14

   Item 1. Condensed Consolidated Financial Statements

   Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about
   8 matches in this document Show context Copy citation

6. VTGN Vistagen Therapeutics, Inc. 10-Q 2025-08-07

   Item 1. Condensed Consolidated Financial Statements

   Liquidity and Going Concern
   5 matches in this document Show context Copy citation